United Health Products Inc (PK) (UEEC) News

Eyes open for the RCA and FDA meeting this week in DC!

https://www.rcainc.com/fdli/
RCA knows Hempstyp gauze forwards and backwards!!

$5-$10++

Not anymore enough is enough!!!!

That’s going way too far Chrism.

Your full of shit and don't have a clue! Dumb Ass!
$5-$10++

White Lion increasing ownership decreases common shareholder ownership,

White Lion and UEEC continue increasing ownership investment and financing.

Date of Sale
Title of Security Number Sold Consideration Received Purchaser/Recipient
January 2024 Common Stock 600,000 $122,627 in cash White Lion (1)
February 2024 Common Stock 850,000 $164,973 in cash White Lion (1)
March 2024 Common Stock 600,000 $103,625 in cash White Lion

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318306575&type=HTML&symbol=UEEC&cdn=1ad91990a3656231d5af5b63e1d6547a&companyName=United+Health+Products+Inc&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2024-05-09

$5-$10+

Very nicely said thank you

Dec 31,2023 YE
ITEM 3. LEGAL PROCEEDINGS
None.

During the year ended December 31, 2023, the Company made the remaining payments owed on the civil penalty and paid $7,638 of post-judgement interest. As of December 31, 2023 the accrued litigation settlement balance was $0.

ALL IN RECENT FINANCIALS...just saying

Someone needs to get outta the DARKNESS OF HOLLYWOOD

I am certain you are comfortable and feel right at home in this element.

Management is digging into pockets. Whose according to SEC?

"FIRST CLAIM FOR RELIEF
Violations of Exchange Act Section IO(b) and Rule 10b-5 Thereunder
(UHP and Beplate)
SECOND CLAIM FOR RELIEF
Violations of Exchange Act Section I0(b) and Rules IOb-S(a) and (c) Thereunder
(Schiliro)
THIRD CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section lO(b) and Rule 10b-5(b)
(Schiliro)
FOURTH CLAIM FOR RELIEF
Violations of Securities Act Section 17(a)
(All Defendants)
FIFTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a), 13(b)(2)(A) and 13(b)(2)(B)
of the Exchange Act and Rules 12b-20, 13a-1 and 13a-13 Thereunder
(UHP)
SIXTH CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section 13(a),
13(b)(2)(A), 13(b)2)B), and Rules 12b-20, 13a-1 and 13a-13
(Beplate and Schiliro)
SEVENTH CLAIM FOR RELIEF
Violation of Section 13(b)(5) of the Exchange Act and Exchange Act Rule 13b2-1
(Beplate and Schiliro)
EIGHTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a) and Rule 13a-14 Thereunder
(Beplate)
NINTH CLAIM FOR RELIEF
Violations of Rule 13b2-2 of the Exchange Act
(Beplate and Schiliro)
TENTH CLAIM FOR RELIEF
Violations of Sarbanes-Oxley Act Section 304(a)
(Beplate)
ELEVENTH CLAIM FOR RELIEF
Violations of Exchange Act Section 16(a) and Rule 16a-3 Thereunder
(Beplate)"
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf

Well Management has been digging into their pockets and funding from White Lion Capital LLC hasn't really been much in way of any dilution then waiting for FDA approvals seems like a good plan, not sure what others would expect.
Patience in some OTC companies is key as not all are get rich quick Hollywood scams

Sorry Wave - was trying to lecture. From your posts, you clearly understand where this is in the process.

Now that we know UEEC is in the FDA process, my point - there won't be much to update on for weeks to come. There are some folks here (again not you, or what appears to be the small minority in this group anymore) that seem to expect daily journal entries with updates.

Agree - Now that we know it's in the hands of the FDA, we are waiting on them (well mostly).

PMA's have been filed for 7 years now...wash, rinse, repeat.

"March 21, 2024, we submitted to the FDA a revised Premarket Approval application"

SO expect will take a bit more time to hear about the revised submission IMO

guess some need info now but with other companies they "support" they don't mind not hearing anything from management for over a year No complaints about being in the Dark !

Stating the specific determination of the 2017 PMA and each specific determination for subsequent PMA's thereafter, including the reasons for the determinations,would be a pleasant place to start. Don't you think? Or is that irrelevant information for the agenda?

From financials..what more can they state?

On March 21, 2024, we submitted to the FDA a revised Premarket Approval application to market our absorbable hemostatic gauze for human surgical applications in the United States. The FDA is currently reviewing our application and there can be no assurance that our PMA application will be approved.

On March 21, 2024, we submitted to the FDA a revised Premarket Approval application to market our absorbable hemostatic gauze for human surgical applications in the United States. The FDA is currently reviewing our application and there can be no assurance that our PMA application will be approved.

Shoondale = Scumbagfraudsters= Zorax

GetRch, interesting that you’re lecturing on patience now. The posts relating to future PRs by Pragmatic and I are clear statements of how the PMA timeline works. And could (should in my opinion) result in a PR.

BTW, where was your patience in March when you wrote:

“8 weeks to review sterilization data and submit is plenty long enough to have given a further update. This tells me that either they submitted and have big news coming, but are fearful of leaks so don't want another PR, or they are clueless on what to do next and are fumbling around looking for a Doug-like expert to bail them out.
Enough is enough Brian - Finish the Deal!”

OR Dec 2023:

“11 weeks is MORE THAN ENOUGH TIME to complete those tests. From the companies I've run, and my experience, If I was Thom, I would be sleeping at the test facility, right next to the testing team and the owners working daily to get this done well, ASAP.
I get "wait and see for shareholders." The wait and see by Thom while the test facility F#*^S around is INEXCUSABLE. Take some ownership and walk the test facility across the finish line.”

Can you name a single time ueec has shared negative news or verified one of their failed PMA attempts? My question goes back for a time period of over a decade. Thanks, in advance, for your response.

No reason for Brian to share any news until the FDA makes an announcement is correct!
$5-$10+

"we doubt that shareholders will hear about it. We expect it will be just like when UEEC applied for PMA approval for Class III in late 2017, there will just not be any updates, like it never happened."
https://seekingalpha.com/article/4300303-united-health-products-press-releases-cannot-be-taken-face-value

As I've stated before. UEEC has zero reason to update shareholders or issue a PR until there is something to actually write about. They are not going to spend money having a PR written that states "Still waiting on the FDA." We must be patient. Patient that the process is executing as it should. That UEEC is providing answers to any questions the FDA may have. That the FDA is following their process, doing site visits as needed, etc.

There is zero benefit for Brian or anyone else at this company to hide information, or slow play this. It's very clear, the eggs are all in one basket . . . getting FDA approval.

Let's all have a bit more patience, and fingers crossed for some good news as soon as the news is actually news and not just rumors or speculation.

It’s amazing how bad you are at this, considering you post so often.
You are a living contrast to the book “Outliers.”
Malcolm will have to do a complete rewrite of his premise.

BTW were you drunk when you wrote this:Now why would someone post opinions that are likely true and need to be drunk?

And the author is trying mightily to deflect that the states matter when shoons point is the connection of the people and events.

And being a stock pumper and possible employee of a stock scam while including the word intelligence is a major misnomer.

That’s pretty sad Zorax. Did you spend the last 3 weeks reviewing my posts (as I suggested) looking for any evidence of a “GRAFT?”
I know that’s an impossible task.

I wanted you to spend the time learning about hemostyp and the PMA process. Not looking for “grafts.”

When I reply to Shoone, and provide clarity that may support his view, then so be it.
I’m not on anyone’s side here. I just provide realistic, fact based information.
I believe I also had to help him when he made a “graft” about Texas and Nevada.
Your tax comment is full of “grafts” as well.
It actually exposes just how desperate you are.
You completely misinterpreted my statement with your “tax friendly “ gibberish.

I didn’t say Nevada was a Tax Free state. I clearly said Zero Taxable Gains.
I also said “hope to go tax free”. Hope. No guarantees.

BTW were you drunk when you wrote this:

“Thanks for that. I'm disappointed that your superior intellect didn't catch your graft. Or as an employee of uhp, just setting up the groundwork for a furture p&d?”

👍️SEC👍️ Charges Rhode Island Stock Promoter with Microcap Fraud
https://www.sec.gov/litigation/litreleases/lr-25993
The companies in question are SOLY, CNSP, EBET, VLCN, TOBAF
The Securities and Exchange Commission today announced charges against Cranston, Rhode Island resident Ahmed Alomari and MCM Consulting, the entity Alomari controls, for fraud and other securities law violations related to their promotion of the stocks of at least five microcap issuers.

The SEC alleges that from at least March 2019 and continuing to February 2022, Alomari used such outlets as Twitter, Instagram, Facebook, investor chatrooms, and text blasts to promote these microcap stocks without disclosing the source or amount of compensation he received from, or on behalf of, the issuers for his promotion of their stocks. The SEC further alleges that Alomari personally invested in some of these issuers' securities, then surreptitiously sold the stocks while publicly recommending that investors buy them. This conduct included two initial public offerings in which Alomari allegedly invested and quickly sold all his shares for at least $1.4 million in profits. According to the SEC's complaint, Alomari also was able to publicly sell shares he had earned from his promotional services based on false representation letters confirming that the shares were available for public trading. The SEC alleges that Alomari directed his wife, whom he named as the sole officer of MCM Consulting, to sign the false representation letters.

The SEC's complaint, filed in the U.S. District Court for the District of Rhode Island, charges Alomari and MCM Consulting with violating the anti-fraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, the anti-touting provisions of Section 17(b) of the Securities Act, which prohibit promotion of a security without disclosure of compensation received for the promotional activity, and the registration provisions of Section 5(a) and (c) of the Securities Act. The SEC's complaint additionally charges Alomari with violating Section 20(b) of the Exchange Act by violating the anti-fraud provisions through or by means of his wife. The complaint seeks, as to both Alomari and MCM Consulting, permanent injunctions from violating the charged provisions of the federal securities laws, disgorgement, prejudgment interest, civil monetary penalties, and a penny stock bar. The complaint also seeks a bar against Alomari from acting as an officer or director of a public company.

The SEC's case is being handled by Richard Harper, Jeffrey Cook, Alexandra Lavin, Jonathan Menitove, Ryan Murphy, and Celia Moore of the SEC's Boston Regional Office.

Interesting. Then you readily admit that there is indeed a company/employer connection between the states and shoon is actually correct in his contentions? Because that was his point after all.

Thanks for that. I'm disappointed that your superior intellect didn't catch your graft. Or as an employee of uhp, just setting up the groundwork for a furture p&d?

By the way, Nevada is tax and filing inc friendly, not tax free.

Their original office was in Nevada.
Former CEO and majority shareholder continues to live in Nevada. Hence, they may as well keep a PO Box and hope to go tax free after the big acquisition.

Pragmatic, I think we here the FDA has accepted the PMA and my feeling is that because of the 3rd party RCA the file is completed fully and we begin the who knows how long wait for approval. JMO

Pragmatic, another accurate post re the current state of the PMA and where it stands with the FDA. Thank You, Hopefully UHP updates Shareholders in a timely manner.
If/when they announce if the FDA has agreed to File the application, Hemostyp will then (and only then) move on to the full review stage.
Typically UHP is quick with positive news, and vague with negative news. We’ll see what happens this time around.

Here’s a quote from the last time Hemostyp got to this stage successfully.

May 5,2021,— yes 3 years ago.

“following the resubmission of its application for Pre-market Approval for HemoStyp gauze on April 6th, the FDA has now accepted for review and commenced its Substantive Review of the application.”

Hopefully there are no resubmissions required this time around. As in that case, the original was submitted Oct 2020.

Shoon, does Halo ring a bell??? Talk about SCUMBAGFRAUDSTERS

Shoondale, is there any stocks that you actually like?
SEEMS you spout the same thing about every stock you follow?
Bit bizarre.
ANYONE have any insight on shoony?

"we doubt that shareholders will hear about it. We expect it will be just like when UEEC applied for PMA approval for Class III in late 2017, there will just not be any updates, like it never happened."
https://seekingalpha.com/article/4300303-united-health-products-press-releases-cannot-be-taken-face-value

Yesterday marked 6 weeks from when UEEC reported that the application was submitted. The FDA has 45 days to review the application, so UEEC should hear something from the FDA by Tuesday at the latest.

UEEC--Heading into another great and GREEN weekDon't think so, heading into a new 52 week low instead.

Market makers have control of this until we get news and the correct volume comes in.. MM’s are just ping ponging it

Couldn’t agree with you more

If we are looking at a 24 week FDA window; we are about 20% thru that evaluation period.
The investment (or gamble) is in the final stretch for a decision. Hard to see any logic for those
selling; I hold to the end. Got to ride this one out.

UEEC--Heading into another great and GREEN week.

TIC TOC

Broker running a stock scam is very beneficial..https://brokercheck.finra.org/individual/summary/4231884
Good volume too !!
https://www.butlercap.com/our-team-2

https://uhpcorp.com/leadership/

Good volume too !!

Anither Green Day!

Another Green Day ?? Cool……$$ UEEC $$

Banjo50, this fraudulent scam isn't worth more than...$0.0001...https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf

🚂Gravy-train🚂 stock-scam 🎪circus🎪. Check out 2013 💩bullshit💩 🍭suckers🍭 were fed; great for laughs:

How is this company still alive. Nothing has changed on progression in 6 years. Sti saying the same thing

Another Green Day !

I think it should be five cents. Five cents is a fair price. I will buy at five cents.